Comparing Biomarkers as Principal Surrogate Endpoints (Q2893405): Difference between revisions

From MaRDI portal
Added link to MaRDI item.
ReferenceBot (talk | contribs)
Changed an Item
 
(3 intermediate revisions by 3 users not shown)
Property / Wikidata QID
 
Property / Wikidata QID: Q28740935 / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2002963026 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Weighted Likelihood for Semiparametric Models and Two‐phase Stratified Samples, with Application to Cox Regression / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q2717985 / rank
 
Normal rank
Property / cites work
 
Property / cites work: The evaluation of surrogate endpoints. / rank
 
Normal rank
Property / cites work
 
Property / cites work: The validation of surrogate endpoints in meta-analyses of randomized experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: Augmented Designs to Assess Immune Response in Vaccine Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Principal Stratification in Causal Inference / rank
 
Normal rank
Property / cites work
 
Property / cites work: Evaluating Candidate Principal Surrogate Endpoints / rank
 
Normal rank
Property / cites work
 
Property / cites work: Semiparametric Estimation of Regression Quantiles with Application to Standardizing Weight for Height and Age in US Children / rank
 
Normal rank
Property / cites work
 
Property / cites work: Evaluating the Predictiveness of a Continuous Marker / rank
 
Normal rank
Property / cites work
 
Property / cites work: Related Causal Frameworks for Surrogate Outcomes / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials / rank
 
Normal rank

Latest revision as of 09:39, 5 July 2024

scientific article
Language Label Description Also known as
English
Comparing Biomarkers as Principal Surrogate Endpoints
scientific article

    Statements

    Comparing Biomarkers as Principal Surrogate Endpoints (English)
    0 references
    0 references
    0 references
    0 references
    20 June 2012
    0 references
    0 references
    estimated likelihood
    0 references
    predictiveness curve
    0 references
    principal stratification
    0 references
    semiparametric
    0 references
    surrogate marker
    0 references
    total gain
    0 references
    0 references
    0 references